Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

709 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRI.
Stoyanova R, Zavala-Romero O, Kwon D, Breto AL, Xu IR, Algohary A, Alhusseini M, Gaston SM, Castillo P, Kryvenko ON, Davicioni E, Nahar B, Spieler B, Abramowitz MC, Dal Pra A, Parekh DJ, Punnen S, Pollack A. Stoyanova R, et al. Among authors: castillo p. Cancers (Basel). 2023 Oct 31;15(21):5240. doi: 10.3390/cancers15215240. Cancers (Basel). 2023. PMID: 37958414 Free PMC article.
Longitudinal Changes and Predictive Value of Multiparametric MRI Features for Prostate Cancer Patients Treated with MRI-Guided Lattice Extreme Ablative Dose (LEAD) Boost Radiotherapy.
Algohary A, Alhusseini M, Breto AL, Kwon D, Xu IR, Gaston SM, Castillo P, Punnen S, Spieler B, Abramowitz MC, Dal Pra A, Kryvenko ON, Pollack A, Stoyanova R. Algohary A, et al. Among authors: castillo p. Cancers (Basel). 2022 Sep 15;14(18):4475. doi: 10.3390/cancers14184475. Cancers (Basel). 2022. PMID: 36139635 Free PMC article.
Uncovering prostate cancer aggressiveness signal in T2-weighted MRI through a three-reference tissues normalization technique.
Algohary A, Zacharaki EI, Breto AL, Alhusseini M, Wallaengen V, Xu IR, Gaston SM, Punnen S, Castillo P, Pattany PM, Kryvenko ON, Spieler B, Abramowitz MC, Pra AD, Ford JC, Pollack A, Stoyanova R. Algohary A, et al. Among authors: castillo p. NMR Biomed. 2024 Mar;37(3):e5069. doi: 10.1002/nbm.5069. Epub 2023 Nov 21. NMR Biomed. 2024. PMID: 37990759
Teaching cancer imaging in the era of precision medicine: Looking at the big picture.
N Chin C, Subhawong T, Grosso J, Wortman JR, McIntosh LJ, Tai R, Braschi-Amirfarzan M, Castillo P, Alessandrino F. N Chin C, et al. Among authors: castillo p. Eur J Radiol Open. 2022 Mar 15;9:100414. doi: 10.1016/j.ejro.2022.100414. eCollection 2022. Eur J Radiol Open. 2022. PMID: 35309874 Free PMC article. Review.
Criteria for melanocytic lesions in LC-OCT.
Perez-Anker J, Soglia S, Lenoir C, Albero R, Alos L, García A, Alejo B, Cinotti E, Orte Cano C, Habougit C, Dorado Cortes C, Pellegrino L, Tognetti L, Castillo P, Rubegni P, Suppa M, Perrot JL, Del Marmol V, Puig S, Malvehy J. Perez-Anker J, et al. Among authors: castillo p. J Eur Acad Dermatol Venereol. 2024 May 10. doi: 10.1111/jdv.20079. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38727525
RNA aggregates harness the danger response for potent cancer immunotherapy.
Mendez-Gomez HR, DeVries A, Castillo P, von Roemeling C, Qdaisat S, Stover BD, Xie C, Weidert F, Zhao C, Moor R, Liu R, Soni D, Ogando-Rivas E, Chardon-Robles J, McGuiness J, Zhang D, Chung MC, Marconi C, Michel S, Barpujari A, Jobin GW, Thomas N, Ma X, Campaneria Y, Grippin A, Karachi A, Li D, Sahay B, Elliott L, Foster TP, Coleman KE, Milner RJ, Sawyer WG, Ligon JA, Simon E, Cleaver B, Wynne K, Hodik M, Molinaro AM, Guan J, Kellish P, Doty A, Lee JH, Massini T, Kresak JL, Huang J, Hwang EI, Kline C, Carrera-Justiz S, Rahman M, Gatica S, Mueller S, Prados M, Ghiaseddin AP, Silver NL, Mitchell DA, Sayour EJ. Mendez-Gomez HR, et al. Among authors: castillo p. Cell. 2024 May 9;187(10):2521-2535.e21. doi: 10.1016/j.cell.2024.04.003. Epub 2024 May 1. Cell. 2024. PMID: 38697107
709 results